Cover [Abstract]
Entity Registrant Name
Entity Central Index Key
Document Type
Amendment Flag
Entity Voluntary Filers
Current Fiscal Year End Date
Entity Well Known Seasoned Issuer
Entity Small Business
Entity Shell Company
Entity Emerging Growth Company
Entity Current Reporting Status
Document Period End Date
Entity Filer Category
Document Fiscal Period Focus
Document Fiscal Year Focus
Entity Common Stock Shares Outstanding
Document Annual Report
Document Transition Report
Document Fin Stmt Error Correction Flag
Entity File Number
Entity Incorporation State Country Code
Entity Address Address Line 1
Entity Address City Or Town
Entity Address Country
Icfr Auditor Attestation Flag
Auditor Name
Auditor Location
Auditor Firm Id
Security 12b Title
Entity Interactive Data Current
Phone Fax Number Description
Contact Personnel Email Address
Contact Personnel Name
Document Accounting Standard
City Area Code
Local Phone Number
Amendment Description
Document Registration Statement
Entity Addresses Address Type [Axis]
Business Contact [Member]
Consolidated Statements of Operations and Comprehensive Loss
Revenues
Sales of goods
Total revenue
[Revenue]
Cost of goods sold and operating Expenses
Cost of goods sold
Research and development
General and administrative
Total operating expenses
[Expenses, by nature]
Loss from operations
[Profit (loss) from operating activities]
Other income (expense)
Loss on conversion of debt
[Loss on conversion of debt]
Other income
Finance income
Finance costs
[Finance costs]
Operating lease interest expense
[Interest expense on lease liabilities]
Loss before income taxes
[Profit (loss) before tax]
Income tax provision (recovery)
Net loss
[Profit (loss)]
Net loss attributable to Nymox shareholders
[Profit (loss), attributable to owners of parent]
Basic and diluted loss per share
Weighted average number of common shares outstanding
Consolidated Statements of Financial Position
ASSETS
Current assets
Cash
Other receivables
Security deposit
Prepaid assets
Bond Deposits
Total current assets
[Current assets]
Property and equipment
Total assets
[Assets]
LIABILITIES AND EQUITY
Current liabilities
Accounts payable and accrued liabilities
Accounts payable to related parties
Accrued interest payable to related party
Advances, related Party
Total current liabilities
[Current liabilities]
Total liabilities
[Liabilities]
Equity
Share capital - unlimited authorized shares at no par value 102,040 and 94,540 shares outstanding at December 31, 2025 and 2024, respectively
Share capital payable
Additional paid-in capital
Accumulated deficit
Total Stockholders' equity (deficit)
[Equity]
Total liabilities and stockholders' equity
[Equity and liabilities]
Number of shares outstanding
Consolidated Statements of Cash Flow
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
Adjustments for:
Loss on debt conversion
Depreciation
Stock-based compensation
Amortization and others
Changes in non-cash operating balances:
Other receivables
[Adjustments for decrease (increase) in trade and other receivables]
Bond Deposits
[Adjustments for increase (decrease) in deposits]
Prepaid assets
[Adjustments for decrease (increase) in prepaid expenses]
Accounts payable and accrued liabilities
[Adjustments for increase (decrease) in trade and other payables]
Net cash used in operating activities
[Cash flows from (used in) operating activities]
CASH FLOWS USED IN INVESTING ACTIVITIES
Purchase of property and equipment
[Purchase of property, plant and equipment, classified as investing activities]
Net cash flows used in investing activities
[Cash flows from (used in) investing activities]
CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES
Proceeds from the issuance of share capital and warrants
Borrowings on debt
Repayment of operating lease and financing obligation
[Payments of lease liabilities, classified as financing activities]
Net cash provided from financing activities
[Cash flows from (used in) financing activities]
Net (decrease) increase in cash
[Increase (decrease) in cash and cash equivalents after effect of exchange rate changes]
CASH
Beginning of year
[Beginning of year]
End of year
SUPPLEMENTAL DISCLOSURE
Income taxes paid
Interest paid
NON-CASH INVESTING AND FINANCING ACTIVITIES
Conversion of note payable, related party, to equity
Forgiveness of accrued and deferred salary1
Equity component of convertible note
Exchange of accounts payable for notes payable
Consolidated Statements of Changes in Equity
Statement [Table]
Statement [Line Items]
Components of equity [axis]
Common Shares
Subscription receivable
Share Capital Payable
Accumulated Deficit
Balance, shares
[Number of shares issued]
Balance, amount
Shares issuance for cash and subscriptions, shares
Shares issuance for cash and subscriptions, amount
Cancellation of accrued salary
Note Payable Converted into Shares, shares
Note Payable Converted into Shares, amount
Warrant issued
Stock-based compensation and service fee, shares
Stock-based compensation and service fee, amount
Net loss
Equity component of convertible note
[Equity component of convertible note]
Balance, amount
Balance, shares
BUSINESS ACTIVITIES AND BASIS OF PRESENTATION
BUSINESS ACTIVITIES AND BASIS OF PRESENTATION
Disclosure of basis of preparation of financial statements [text block]
GOING CONCERN CONSIDERATIONS
GOING CONCERN CONSIDERATIONS
Disclosure of going concern [text block]
SIGNIFICANT ESTIMATES
SIGNIFICANT ESTIMATES
Disclosure of changes in accounting estimates [text block]
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES
Disclosure of changes in accounting policies [text block]
NEW ACCOUNTING STANDARDS AND INTERPRETATIONS
NEW ACCOUNTING STANDARDS AND INTERPRETATIONS
[NEW ACCOUNTING STANDARDS AND INTERPRETATIONS]
PROPERTY AND EQUIPMENT
PROPERTY AND EQUIPMENT
Disclosure of property, plant and equipment [text block]
BOND DEPOSITS
BOND DEPOSITS
[BOND DEPOSITS]
INTANGIBLE ASSETS
INTANGIBLE ASSETS
Disclosure of intangible assets [text block]
ADVANCES RELATED PARTY
ADVANCES RELATED PARTY
Disclosure of related party [text block]
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
Disclosure of accrued expenses and other liabilities [text block]
OPERATING LEASES AND COMMITMENTS
OPERATING LEASES AND COMMITMENTS
Disclosure of maturity analysis of operating lease payments [text block]
SHARE CAPITAL
SHARE CAPITAL
Disclosure of classes of share capital [text block]
STOCK OPTIONS
STOCK OPTIONS
[STOCK OPTIONS]
SHARE BASED COMPENSATION
SHARE BASED COMPENSATION
Disclosure of share-based payment arrangements [text block]
WARRANTS
WARRANTS
[WARRANTS]
INCOME TAXES
INCOME TAXES
Disclosure of income tax [text block]
EARNINGS PER SHARE
EARNINGS PER SHARE
Disclosure of earnings per share [text block]
FINANCIAL INSTRUMENTS FAIR VALUE DISCLOSURES
FINANCIAL INSTRUMENTS FAIR VALUE DISCLOSURES
Disclosure of fair value of financial instruments [text block]
FINANCE INCOME AND FINANCE COSTS
FINANCE INCOME AND FINANCE COSTS
Disclosure of finance cost [text block]
SEGMENT DISCLOSURES
SEGMENT DISCLOSURES
Disclosure of operating segments [text block]
CONCENTRATIONS
CONCENTRATIONS
[CONCENTRATIONS]
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS
Disclosure of transactions between related parties [text block]
RESEARCH AND DEVELOPMENT EXPENSES
RESEARCH AND DEVELOPMENT EXPENSES
Disclosure of research and development expense [text block]
PERSONNEL EXPENSES
PERSONNEL EXPENSES
Disclosure of expenses [text block]
CAPITAL DISCLOSURES AND FINANCIAL RISK
CAPITAL DISCLOSURES AND FINANCIAL RISK
Disclosure of financial risk management [text block]
FOREIGN EXCHANGE RISK
FOREIGN EXCHANGE RISK
Disclosure of effect of changes in foreign exchange rates [text block]
CREDIT RISK
CREDIT RISK
Disclosure of credit risk [text block]
INTEREST RATE RISK
INTEREST RATE RISK
[INTEREST RATE RISK]
LIQUIDITY RISK
LIQUIDITY RISK
Disclosure of liquidity risk [text block]
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES
Disclosure of commitments and contingent liabilities [text block]
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS
Disclosure of events after reporting period [text block]
Consolidation
Financial instruments
Financial assets
Financial liabilities
Share capital
Inventory
Property and equipment
Description of accounting policy for property, plant and equipment [text block]
Research and development expenditures
Amortization
Impairment
Revenue recognition
Sale of goods
Foreign currency
Stock-based compensation
Description of accounting policy for share-based payment transactions [text block]
Employee benefits
Operating leases
Income taxes
Earnings per share
Provisions
Onerous contracts
Schedule of estimated useful lives of property and equipment
Schedule of detail of accountung standard, amendment and improvements
Schedule of property and equipment
Schedule of accounts payable and accrued liabilities
Schedule of operating lease right of use asset
Schedule of operting lease liabilities
Detail of contributed capital by controlling shareholders
Schedule of stock option activity
Schedule of weighted average assumtion using binomial option pricing model
Schedule of stock option-based compensation expense
Schedule of warrant activity
Schedule of effective tax rate reconciliation
Schedule of deferred tax assets
Schedule of weighted average number of common shares outstanding
Schedule of finance income and finance costs
Schedule of reportable segment
Schedule of segment profit or loss
Schedule of customer concentration based on revenue threshold
Schedule of related party transaction
Schedule of key management personnel compensation
Schedule of research and development expenses
Schedule of employee personnel related expenses
Schedule of contractual maturities of financial liabilities
Property, plant and equipment by operating lease status [axis]
Laboratory Equipment [Member]
Office Equipment And Fixtures [Member]
Computer Equipment [Member]
Property and equipment estimated useful lives
Redesignation [axis]
January 1, 2019 [Member]
Immaterial cumulative adjustment
Bond deposits
Office equipment [member]
Computer equipment [Member]
Beginning balance
[Property, plant and equipment, revalued assets, at cost]
Additions
Disposals
Ending balance
Accumulated depreciation, beginning balance
[Accumulated depreciation, beginning balance]
Accumulated depreciation, depreciation for the year
Accumulated depreciation, Disposals for the year
Accumulated depreciation, ending balance
Carrying value of property and equipment
Depreciation expense of property and equipment
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Accumulated amortization [Member]
Gross [Member]
Intangible assets
Categories of related parties [axis]
Counterparties [axis]
Paul Averback [Member]
James G. Robinson [Member]
Extension to loan agreement[Member]
Addendum [Member]
Equity component of the convertible note
Advances for legal expenses
Current portion of borrowings
Remittance received
Additional investment, amount
Issue of initial note
Share price per share
Additional investment, shares
Number of shares issued
Accrued interest on borrowings
Loan amount extending description
Purchase price per share
Equity component recognized
Total equity component in APIC
Amortization
[Amortization]
Amortization relating to advances
Unamortized discount
Market rate
Aggregate equity component
Equity component recognized
[Equity component recognized]
Amortization cost
Interest expense
Conversion price per common share
Maximum shares issuable under conversion feature
Maximum convertible debt
Accounts payable
Payroll related liabilities
Other accrued liabilities
Accounts payable and accrued liabilities
[Trade and other current payables]
Accounts payable to related parties (Note 22)
Accrued interest payable to related party (Note 9)
Total
[Total]
Dr Paul Averback [member]
Mr Patrick Doody [member]
Dr David Morse [member]
Mr James G Robinson [member]
Related Parties [member]
Accounts payable to related parties
Accrued interest payable to related party
Operating lease rou, beginning balance
[Right-of-use assets]
Adjustments office lease
Accumulated amortization
Operating lease rou, ending balance
Operating Lease Liabilities, beginning balance
[Lease liabilities]
Adjustments office lease
Repayments of lease liability
Interest expense
[Interest expense]
Operating lease liabilities, ending balance
Lease liability due within one year
Lease Liability long Term
Immaterial cumulative adjustment
[Immaterial cumulative adjustment]
Number of common shares issued
Number of common shares, value
Patrick Doody [Member]
Number of common shares issued
Restricted stock awarded
Number of shares issued
Classes of share capital [axis]
Stock Option [Member]
Number of outstanding balance, beginning
[Number of share options outstanding in share-based payment arrangement]
Expired
Cancelled
Granted
Number of outstanding balance, ending
Options exercisable
[Options exercisable]
Weighted average exercise price, balance at beginning
[Weighted average exercise price, balance at beginning]
Weighted average exercise, Expired
Weighted average exercise, Cancelled
Weighted average exercise, Granted
Weighted average exercise price, balance at ending
Weighted average exercise price, exercisable
[Weighted average exercise price, exercisable]
Weighted average remaining contractual life (in years) Outstanding, Beginning balance
Weighted average remaining contractual life (in years), Granted
Weighted average remaining contractual life (in years) Outstanding, Ending balance
Weighted average remaining contractual life options exercisable (in years)
Share price
Exercise price
Share price, maximum
Share price, minimum
Risk-free interest rate, minimum
Expected dividend yield
Expected option life in years
Expected volatility
Risk-free interest rate
Risk-free interest rate, maximum
Expected volatility, maximum
Expected volatility, minimum
Maximum number of share available for stock option
Issued and outstanding common shares perctange
Stock option granted
Weighted average grant-date fair value of options granted
Classes of assets [axis]
General And Administrative Expenses [member]
Research And Development Expenses [member]
Stock option-based compensation expense
Dr Averback [member]
Total restricted shares granted
Monthly restricted shares granted
Fair value per share
Compensation expense
Proceeds from issuance of stock
Share-based payment expense
Back pay settled through equity instruments
Restricted shares granted
Types of antidilutive instruments [axis]
Warrants [Member]
Number of outstanding balance, beginning
[Number of outstanding balance, beginning]
Exercised
Granted
[Granted]
Expired
[Expired]
Cancelled
[Cancelled]
Number of outstanding balance, ending
Weighted average exercise price, balance at beginning
[Weighted average exercise price, balance at beginning 1]
Weighted average exercise, Exercised
Weighted average exercise, Granted
[Weighted average exercise, Granted]
Weighted average exercise, Expired
[Weighted average exercise, Expired]
Weighted average exercise, Cancelled
[Weighted average exercise, Cancelled]
Weighted average exercise price, balance at ending
Weighted average remaining contractual life (in years) Outstanding, Beginning balance
[Weighted average remaining contractual life (in years) Outstanding, Beginning balance]
Weighted average remaining contractual life (in years), Granted
Weighted average remaining contractual life (in years) Outstanding, Ending balance
Classes of financial assets [axis]
Private Placements [Member]
Share price per share
Warrants issued
Warrants recorded in APIC
Biological assets by age [axis]
Segments [axis]
Bahamas [Member]
United States [Member]
Net loss for the year, before income taxes
Domestic tax rate applicable to the Corporation
Net loss for the year, before income taxesBE
Income taxes at domestic tax statutory rate
Change in valuation allowance
Deferred tax provision (recovery)
Tax loss carry forward
Patents capitalized and amortized for tax purposes
Unrecognized deferred tax assets
Maximum future annual taxable income percentage
Canadian research tax credit carryforwards
Canadian loss carryforwards
Net operating loss carry-forwards
Issued common shares at January 1
[Issued common shares at January 1]
Effect of shares issued
Weighted average number of common shares outstanding at December 31
[Weighted average number of common shares outstanding at December 31]
Basic and diluted loss per share
[Basic and diluted loss per share]
Net loss
[Net loss]
Interest income
Net foreign exchange gain (loss)
Finance income
Financial costs (Interest and bank charges)
[Financial costs (Interest and bank charges)]
Operating lease interest expense
[Operating lease interest expense]
Total finance income and costs
Research and development costs
General and Administrative costs
Finance Costs
Europe [Member]
United States [Member]
[United States [Member]]
Canada [Member]
Revenue
Property and equipment
Types of customers [axis]
Customer A [Member]
Customer B [Member]
Customer C [Member]
Sales of goods
Directors [Member]
Notes payable to related party
Compensation to officers
Total Transactions for year
Salary and Compensation
Short-term employee benefits
Stock-based compensation
[Key management personnel compensation, share-based payment]
Total
[Key management personnel compensation]
Chief Financial Officers [Member]
Corporate Legal Counsel [Member]
James G Robinson [Member]
Notes payable to related parties
Equity component of convertible instrument
Equity component of compound financial instrument
Interest expense
Unamortised discount on loans and receivables
Carrying amount of advances from a related party
Salary compensation
Amounts paid contract for services
Key management personnel compensation of general and administrative expense
Key management personnel compensation of stock-based compensation
Key management personnel compensation of research and development expense
Short-term loan agreement, Description
First loan payment received
Second loan payment received
Original loan amount
Debt conversion of common stock
Total borrowings
Purchase price per share
Associates [axis]
Research and Development Program [Member]
Alzheimers Disease Therapeutics [Member]
Anti-Infectives [Member]
BPH (Enlarged Prostate) and Prostate Cancer Therapeutics [Member]
Tobacco Exposure Tests: NicAlert? and TobacAlert? [Member]
Research and development expenses
Salaries and compensation
Employer contributions
Short-term employee benefits
[Short-term employee benefits expense]
Denominated percentages of expenses
Description of functional currency exposures
Trade accounts receivable
Increase decrease interest rates percentage description
Maturity [axis]
Carrying Amount [Member]
Less than 1 year [Member]
1 year to 5 years [Member]
Accounts payable and accrued liabilities
Non-adjusting events after reporting period [axis]
Events After Reporting Period [Member]
Dr. Paul Averback
Liabilities from share-based payment transactions
Principal advances owed to Mr. Robinson
Accrued and unpaid interest
Convertible borrowing / convertible loan
Number of shares issuable upon conversion
Conversion price
Maximum number of shares issued under conversion
maximum shares issuable under the option
Increase in number of shares outstanding